Physician profile
Adam P Murchie
NPI 1528063914
$5,911.99
in general payments reported to CMS, 2019-2025
13 companies · $1,365 in 2025
The $1,365 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,362 · 2022: $1,172 · 2023: $727 · 2024: $1,286 · 2025: $1,365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,378.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,563.39 | 2021-2025 | Gamma, Reunion, Pangea |
| Ethicon US, LLC | $286.63 | 2021-2023 | Endopath Xcel |
| Depuy Synthes Sales INC. | $235.37 | 2022-2024 | Vivigen Mis Delivery System, Fibergraft Aeridyan Matrix |
| Tela Bio, INC. | $153.92 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Smith+Nephew, INC. | $151.55 | 2023-2025 | Healicoil, Bone Anchors With Arthroscopic Delivery System, Rf20000 |
| Kerecis Limited | $126.26 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Abbott Laboratories | $125.06 | 2022-2025 | Ionicrf, Proclaim |
| Mvp Orthopedics INC | $114.45 | 2021 | |
| Cipher Pharmaceuticals US LLC | $61.05 | 2025 | Spinosad, Natroba |
| Esperion Therapeutics, INC. | $45.35 | 2021 | |
| Si-Bone, INC. | $17.79 | 2025 | |
| Medical Device Business Services, INC. | $16.23 | 2021 | |
| Bioventus LLC | $14.94 | 2024 | Bonescalpel & Sonicone (O.R.) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Murchie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.